Intercept Pharmaceuticals, Inc. (ICPT) financial statements (2020 and earlier)

Company profile

Business Address 10 HUDSON YARDS, 37TH FLOOR
NEW YORK, NY 10001
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments653436415689628240145
Cash and cash equivalents70437044332013
Short-term investments583393345646595220131
Restricted cash and investments5      
Receivables3826179   
Inventory, net of allowances, customer advances and progress billings8732  
Inventory8732   
Prepaid expense  1561041
Deposits current assets      0
Other undisclosed current assets1713(1)1431
Total current assets:721482448708642246148
Noncurrent Assets
Inventory, Noncurrent8      
Property, plant and equipment51016111062
Other noncurrent assets13      
Other undisclosed noncurrent assets7162020421
Total noncurrent assets:342736311483
TOTAL ASSETS:755509484739656254150
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities814042334633
Accounts payable191277433
Accrued liabilities2877730  
Employee-related liabilities2620271911  
Interest and dividends payable8      
Debt6      
Deferred revenue and credits226222
Other undisclosed current liabilities74736140 104
Total current liabilities:1621141047947159
Noncurrent Liabilities
Long-term debt and lease obligation532371356341   
Long-term debt, excluding current maturities532371356341   
Liabilities, other than long-term debt9584689
Deferred revenue and credits134689
Other liabilities946    
Other undisclosed noncurrent liabilities      50
Total noncurrent liabilities:5413763643466859
Total liabilities:703490468424542368
Stockholders' equity
Stockholders' equity attributable to parent, including:52191631560223182
Common stock0000000
Additional paid in capital2,1761,8001,4871,4261,300700268
Accumulated other comprehensive income (loss)(1)(2)(1)(3)(2)(0)0
Accumulated deficit(2,123)(1,779)(1,470)(1,108)(696)(469) 
Other undisclosed stockholders' equity attributable to parent      (186)
Total stockholders' equity:52191631560223182
TOTAL LIABILITIES AND EQUITY:755509484739656254150

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues25218013125322
Revenue, net13125322
Cost of revenue(4)(3)(1)    
Cost of goods and services sold (3)(1)    
Gross profit:24817713025322
Operating expenses(560)(465)(467)(427)(232)(115)(41)
Other operating income, net     10
Other undisclosed operating income 31    
Operating loss:(312)(285)(336)(403)(229)(113)(39)
Nonoperating income (expense)(32)(24)(25)(10)3(170)(28)
Investment income, nonoperating    (6)(3)(2)
Other nonoperating income9754   
Interest and debt expense(41)(31)(29)(14)   
Other undisclosed income from continuing operations before equity method investments, income taxes41312914   
Net loss:(345)(309)(360)(413)(226)(283)(68)
Other undisclosed net income (loss) attributable to parent     (0)0
Net loss available to common stockholders, diluted:(345)(309)(360)(413)(226)(283)(68)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(345)(309)(360)(413)(226)(283)(68)
Other comprehensive income (loss)1 (358)(413)(228)(284)(68)
Comprehensive loss:(344)(309)(719)(826)(455)(566)(136)
Other undisclosed comprehensive loss, net of tax, attributable to parent (1)     
Comprehensive loss, net of tax, attributable to parent:(344)(311)(719)(826)(455)(566)(136)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: